Transplantation proceedings

publication venue for

Finding Nivo: A Case Report of 2 Forms of Nivolumab-Induced Liver Injury in an Allograft Liver in the Immediate Post-Transplant Period. 2022
Liver Transplantation for Severe Alcoholic Hepatitis: Report of a Single Center Pilot Program.. 50. 2018
The Pancreas Can Take the Cold: Lower Waitlist Times Through Importation.. 49. 2017
Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database.. 47. 2015
Cardiovascular risk assessment among potential kidney transplant candidates and perioperative outcome: analysis of 75 consecutive Middle Eastern patients.. 43. 2011
Preservation of recipient middle hepatic vein for drainage of anterior sector veins in adult-to-adult living-donor liver transplantation.. 41. 2009
2007: the year of regulatory change.. 41. 2009
Prisoners as organ donors: is it worth the effort? Is it ethical?. 41. 2009
Open abdomen management with human acellular dermal matrix in liver transplant recipients.. 40. 2008
The market of human organs: a window into a poorly understood global business.. 40. 2008
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.. 39. 2007
Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.. 39. 2007
Changes in abdominal wounds following treatment with sirolimus and steroids in a rat model.. 38. 2006
Examination of gene expression profile of functional human pancreatic islets after 2-week culture.. 38. 2006
Microscopic intrarenal particles after pulsatile machine preservation do not adversely affect outcomes after renal transplantation.. 38. 2006
Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection.. 38. 2006
Difficult vascular access in patients with end-stage renal failure.. 38. 2006
Liver transplantation for hepatitis B in the United States.. 37. 2005
The impact of total plasma exchange on early allograft dysfunction.. 36. 2004
Pushing the envelope in renal preservation; improved results with novel perfusate modifications for pulsatile machine perfusion of cadaver kidneys.. 36. 2004
An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides.. 33. 2001
Death of alloreactive T cells sets the stage for immunoregulation to act.. 33. 2001
Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.. 33. 2001
Psychiatric complications after liver transplantation.. 33. 2001
Ten years of chronic immunosuppressive therapy following orthotopic liver transplantation: impact on health and quality of life.. 33. 2001
Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.. 33. 2001
Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression.. 33. 2001
Posttransplant lymphoproliferative disorders: single center experience.. 33. 2001
Renal allograft surveillance by mRNA profiling of urinary cells.. 33. 2001
Immunologic monitoring: implications for treatment of rejection.. 32. 2000
T-cell antigen recognition and costimulatory pathways: implications for the induction of transplantation tolerance.. 32. 2000
Is common femoral artery flow affected by the ipsilateral transplanted kidney?. 31. 1999
Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection.. 31. 1999
Prolonged patency of hamster aortic xenografts in rat by cryopreservation.. 30. 1998
Construction, function and in vivo expression of a complement receptor type 1 containing recombinant adenovirus for use in xenotransplantation.. 29. 1997
Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.. 25. 1993
Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1.. 24. 1992
Neopterin, amyloid A, C-reactive protein, gamma-interferon, and interleukin-2 receptor in diagnosis of posttransplantation rejection.. 23. 1991
Analysis of spontaneous blastogenesis profiles in recipients of renal allografts.. 21. 1989
Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation?. 21. 1989
Identification of the nature of hemostatic failure during transplantation of the liver.. 21. 1989
Prevention of pulmonary edema in autoperfusing heart-lung preparation by FUT-175 and leukocyte depletion.. 21. 1989
Resuscitation and preservation of agonally arrested hearts for transplantation: a study of 24 hour stored canine hearts.. 21. 1989
Signaling via the T-cell antigen receptor heterodimer and the CD2 antigen: a novel, synergistic pathway for activation of T-cells.. 21. 1989
The mechanism of discordant xenograft rejection.. 21. 1989
The role of natural suppression in mediating resistance to antibody-facilitated bone marrow engraftment.. 21. 1989
Failure to induce chimerism or tolerance in mice with monoclonal anti-T cell antibodies plus allogeneic bone marrow infusion.. 20. 1988
Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins.. 20. 1988
Intermediate normothermic hemoperfusion of rat kidneys: functional aspects and a study into the effect of free radical scavengers.. 20. 1988
Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation.. 20. 1988
Effects of in vivo administration of human recombinant IL-2 to cynomolgus monkeys after autologous bone marrow transplantation.. 19. 1987
Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.. 19. 1987
Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristics.. 19. 1987
HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.. 19. 1987
In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis.. 19. 1987
The diagnostic, prophylactic, and therapeutic uses of monoclonal antibodies to human cytomegalovirus.. 19. 1987
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin).. 19. 1987
Allotransplantation of cultured retinal epithelium to Bruch's membrane in the rabbit eye.. 19. 1987
An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.. 19. 1987
Cell cycle analysis of activated mononuclear blood cells of renal allograft recipients.. 19. 1987
Current developments in marrow transplantation.. 19. 1987
Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.. 19. 1987
Increased incidence of immediate function after cadaveric kidney transplantation resulting from lidocaine pretreatment of the donor.. 19. 1987
Intermediate normothermic hemoperfusion doubles safe cold preservation of rat kidneys.. 19. 1987
Optimization of donor specific blood transfusion in kidney transplantation.. 19. 1987
Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.. 19. 1987
T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.. 19. 1987
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.. 19. 1987
Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents.. 13. 1981
Alloantigen-independent activation of alloimmune memory cells by soluble factors from mitogen-primed cells.. 13. 1981
Papovavirus excretion following marrow transplantation: incidence and association with hepatic dysfunction.. 13. 1981
Total lymphoid irradiation (TLI) and allogeneic marrow transplantation for enzyme replacement therapy and immunotherapy of leukemia in mice.. 13. 1981
Immunosuppression and tolerance after total lymphoid irradiation (TLI).. 12. 1980
Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.. 12. 1980
Association of HLA in immune response to influenza-A immunization.. 11. 1979
Generation of specific secondary cytotoxic T cells by treatment of long-term primary MLC cells with sodium periodate.. 11. 1979
The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.. 11. 1979
Adverse presensitization: detection by utilization of B lymphoblastoid cell panels.. 11. 1979
Immunosuppressive properties of placental-source gamma globulin: results of a 5-year clinical investigative study in a cadaver kidney transplant program.. 11. 1979
Transplantation tolerance after total lymphoid irradiation.. 11. 1979
Use of HLA genotypically different donors in bone marrow transplantation.. 11. 1979
HLA-D activity in lymphocyte subcellular fractions.. 10. 1978
Regulation of human mixed lymphocyte culture reactions: augmentation of proliferation and generation of cytotoxic cells.. 10. 1978
Response to wheat antigen in in vitro lymphocyte transformation among HLA-B8-positive normal donors.. 10. 1978
Anti-Ia antibody eluted from rejected human renal allografts.. 10. 1978
Detection of anti-donor "Ia" antibodies: a strong correlate of rejection.. 10. 1978
Posttransplant immunologic monitoring of the renal allograft recipient.. 10. 1978
Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens.. 10. 1978
Intragraft immune events causing vascularized organ graft rejection.. 10. 1978
Evidence for close association between B-cell Fc receptors and Ia antigens, and independence from HLA-A,B locus-determined antigens.. 9. 1977
Immunologic monitoring in the diagnosis of renal allograft rejection.. 9. 1977
Presensitization to donor B-cell ("Ia") antigens is associated with early allograft failures.. 9. 1977
Biologic immunosuppression in renal transplantation using retroplacental (maternal) source gamma globulin.. 9. 1977
Use of total lymphoid irradiation in tissue transplantation in mice.. 9. 1977
Hematologic analysis of clinical bone marrow grafting evaluated by in vitro cultures.. 8. 1976
Retroplacental serum factors and passive enhancement.. 8. 1976
Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.. 4. 1972
Induction of tolerance to antilymphocyte globulin in man.. 3. 1971
Articles published in Transplant Proceedings (Guarrera et al 36(5):1257- 60, Polyak et al 32(1):32-4, Polyak et al 31(5):2091-3, Polyak et al 29(8):3582-3).. 37. 2005
Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. 1996
Current concepts of leukemia and results of recent treatment programs. 1978
Severe combined immunodeficiency: transplantation approaches for patients lacking an HLA genotypically identical sibling. 1978
Relevance of major human histocompatibility determinants in clinical bone marrow transplantation. 1976
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection. 1977

VIVO Weill Cornell Medical College

Transplantation proceedings Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)